Ligand id: 8401

Name: evacetrapib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 8
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 87.38
Molecular weight 638.28
XLogP 8.25
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Phase III clinical trials are underway to evaluate evacetrapib as a treatment for primary hypercholesterolemia (June 2015).
Mechanism Of Action and Pharmacodynamic Effects
CETP facilitates the transport of cholesteryl esters and triglycerides between the lipoproteins. Inhibition of this enzyme reduces LDL-cholesterol levels [2-3].